• search
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cell Line Engineering Services

Cell Line Engineering Services

Recombinant cell line development for wide range of protein classes.

Our cell engineering services cater to both tool or reagent and biological product development requirements. We have strong expertise to generate recombinant or stable cell lines for complex and wide protein class targets such as:

RTKs GPCRs Ion channels Immune modulation ligands or receptors Fc-gamma receptors GPI-anchored TNF-receptor superfamily Cell adhesion molecules Transporters Co-receptors Reporter genes

We are well-versed in working with different cellular backgrounds such as established cancer cell lines and primary cells. Hard-to-transfect cell lines required for binding studies, functional assays, immunization in vitro or in vivo screening and efficacy evaluation applications are successfully engineered to achieve the desired attributes.

For biologics programs, we have experience of product development for mAbs, immune-fusion molecules and cytokines. The typical activities includes: transfection, selection, Limiting dilution, media/feed screening, cell line characterization, research cell banking and protein production

Speak to our experts

Cell Lines

  • Membrane-bound receptor cell lines with expression calibrated clones (low, medium and high)
  • Receptor density measured and clones selected as per end-use requirement
  • Knock-In (KI), Knock-Down (KD) and Knock-Out (KO) cell lines using siRNA / shRNA and CRISPR/Cas9 or TALEN technologies
  • Single, double or multiple gene KO / KD in primary and established cell lines
  • Inducible cell line using Tet / Cumate inducible system
  • Reporter cell lines (Fluorescent protein / Luciferase)
  • Orthotopic cell line for in vivo xenograft and imaging applications
  • Production cell lines using commercially available systems such as Freedom CHO-S/CHO DG44/CHOZN and in-house developed lentiviral system
  • SARS-CoV-2 pseudo virus generation and neutralization assay

Vector Systems

pcDNA series, pLVX and pGIPZ / pTRIPZ lentiviral vector series, pCHO1.0, pOptivec, pGL and in-house modified vector systems

Transfection Methods

  • Standard (lipid/nanoparticle)
  • Electroporation
  • Transposon
  • Lentiviral transduction


  • Flow cytometry
  • Western blot
  • Octet
  • ClonePix

Quality Control

  • Thaw test
  • Mycoplasma
  • Clonal stability
  • Receptor density estimation
  • LC-MS analysis

Why Aurigene Pharmaceutical Services?

Strong framework data recording and traceability

Recombinant cell lines for wide protein classes

In-house lentiviral platform for difficult to express reagent proteins

Extensive experience working with various vector or cell line systems

Virtual Tour


Contact Us

CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

JUNE 28, 2022

Neoantigen Specific T cells For Cancer Immunotherapy

Neoantigen specific T cells for cellular cancer immunotherapy An effective anti-tumor immune response in human is marked by presence of T cells reactive against neoantigens. Neoantigens are HLA-bound unique peptides arise from tumor-specific somatic mutations. Neoantigens are highly immunogenic because they are not present in normal tissues and hence...

Read More

Building successful long-term partnerships with CDMOs from early drug discovery through commercialization

Building successful long-term partnerships with CDMOs from early drug discovery through commercialization Maximizing efficiency in drug research, development, and manufacturing is crucial for turning new innovations into therapeutic and financial benefits. Over the past couple of decades, pharmaceutical companies have increasingly turned to contr...

Read More

Technology meets sustainability - How a complex API development process goes green

We are always looking for ways to enhance the sustainability of our products and services. Our team successfully developed a scalable manufacturing process for the API product of one of our Biotech clients using eco-friendly manufacturing technologies. Read the case study to learn more. ...

Read More

Alternate end-game strategies towards Nirmatrelvir synthesis: Defining a continuous flow process for the preparation of an anti-COVID drug


Scalable alternate end-game strategies for the synthesis of the anti-COVID drug molecule Nirmatrelvir (1,PF-07321332) have been described. The first involves a direct synthesis of 1 via amidation of the carboxylic acid 7 (suitably activated as a mixed anhydride with either pivaloyl chloride or T3P) with the ...

Read More
View All

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.